Cortes-Vega A, Chávez-Martínez EA, Ochoa-Madrigal MG, Meneses-Luna O

Language: Spanish
References: 10
Page: 8-16
PDF size: 240.63 Kb.

ABSTRACT

Schizophrenia is perhaps the pathology most commonly associated with the medical branch of psychiatry, however, it only affects 1%1 of the general population, but due to the broad and striking clinical picture, it has become for the population and professionals of health, a topic of interest. Presentations in the infant-juvenile population are associated with varied clinical symptoms, with greater impact on school life, propensity for inadequate response to treatment, greater presentation of side effects and greater cognitive impairment. In this case report, it presents an adolescent with a complex perinatal history, difficulties with socialization, depressive- type affective symptoms with subsequent appearance of severe psychotic symptoms that caused dysfunction in multiple areas, affecting comprehensive development and compromising her quality of life2. The approach to the presentation of a psychotic disorder at an early age, follow-up over time and the importance of making adjustments in the pharmacological treatment until the medication with which the symptomatology is better controlled is explored, considering the importance of avoiding side effects derived from the use of antipsychotics in infant-juvenile patients, where the range of possible treatments is still limited. Conclusion: The present case highlights the complexity of the diagnosis and treatment of early-onset schizophrenia in adolescence, as well as the importance of a comprehensive approach that addresses both the medical, psychological and social aspects of the disease to achieve sustained improvement and quality of life, optimal for the patient.

REFERENCES

1. Sadock BJ, Sadock VA, Ruíz P, Kaplan HI. Kaplan-SadockSinopsis de Psiquiatría: ciencias de la conducta, psiquiatríaclínica. L’hospitalet De Llobregat, Barcelona WoltersKluwer D.L.; 2015.

2. Starling J. Psiquiatra del Niño y Adolescente. DirectoraW. Esquizofrenia y otros trastornos psicóticos de iniciotemprano [Internet]. Available from: https://iacapap.org/_Resources/Persistent/3a193e33111af06ea4574e77f77bf08295f7db8b/H.5-SCHIZOPHRENIA-Spanish-2018.pdf

3. Thapar A. Rutter’s child and adolescent psychiatry. Chichester,West Sussex: Wiley Blackwell; 2018.

4. Huertas R. En torno a la construcción social de la locura.Ian Hacking y la historia cultural de la psiquiatría. Revistade la Asociación Española de Neuropsiquiatría [Internet].2011;31(111):437-456. Recuperado de: https://www.redalyc.org/ articulo.oa?id =265020921004

5. Torres-Lugo D, Castillo-Ledo I, Rojas-Díaz I, Masot-RangelA, Masot-Torres S, Cabrera-Pérez A. La esquizofrenia:una mirada desde la ciencia, la tecnología y la sociedad.Revista Finlay [Internet]. 2022 [citado 2024 Jul 29]; 12(3):[aprox. 8 p.]. Disponible en: https://revfinlay.sld.cu/index.php/finlay/article/view/1173

6. American Psychiatric Association. Diagnostical and StatisticalManual of Mental Disorders V. Washington, edition,2013.

7. Zamanpoor M. Schizophrenia in a genomic era. PsychiatricGenetics. 2020 Feb; 30(1):1-9.

8. Sunshine A, McClellan J. Practitioner Review: Psychosisin children and adolescents. Journal of Child Psychologyand Psychiatry. 2023 Mar 6;64(7).

9. Wang Y, Wang X, Larsen F, Cahill D, Argie Zoubroulis,Ward C, et al. Population Pharmacokinetic Analysis ofBrexpiprazole to Support its Indication and Dose Selectionin Adolescents with Schizophrenia. Journal of ClinicalPharmacology. 2023 Aug 1;63(11):1290–9.

10. Crump CJ, Hagar Abuelazm, Ibrahim K, Shah S, El-MallakhRS. An overview of the efficacy and safety of Brexpiprazolefor the treatment of schizophrenia in adolescents.Expert Review of Neurotherapeutics. 2024 Jul 5;1-7.